A case of systemic lupus erythematosus with pure red cell aplasia possibly caused by persistent infection of human parvovirus B 19

Japanese Journal of Clinical Immunology

Volumn 21, Issue 5, 1998, Pages 220-225

  Mitsunaka, Hiroki ^a   Tokuda, Michiaki ^a   Takahara, Jiro ^a   Matoba, Kenichiro ^b   Miyawaki, Shoji ^b  

^a KAGAWA UNIVERSITY   (Japan)

^b University of Tokyo   (Japan)

Author keywords

Anti phospholipid syndrome; Human parvovirus B 19; Pure red cell aplasia; Systemic lupus erythematosus

Indexed keywords

METHYLPREDNISOLONE; PREDNISOLONE;

AGED; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CASE REPORT; DRUG PULSE THERAPY; FEMALE; HUMAN; IMMUNE DEFICIENCY; IMMUNOLOGY; OPPORTUNISTIC INFECTION; PARVOVIRUS; PURE RED CELL ANEMIA; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME; VIRUS INFECTION;

AGED; ANTIPHOSPHOLIPID SYNDROME; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; LUPUS ERYTHEMATOSUS, SYSTEMIC; METHYLPREDNISOLONE; OPPORTUNISTIC INFECTIONS; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; PREDNISOLONE; PULSE THERAPY, DRUG; RED-CELL APLASIA, PURE; TREATMENT OUTCOME;

EID: 0032228988     PISSN: 09114300     EISSN: 13497413     Source Type: Journal    
DOI: 10.2177/jsci.21.220     Document Type: Article

References (8)

1. Kurtzman, G., Frickenhofen, N., Kimball, J., et al.: Pure red cell aplasia of 10 years’ duration due to persistent parvovirus B 19 infection and its cure with immunoglobulin therapy. N. Engl. J. Med., 321: 519–523, 1989.
2. Cassileth, P.A., Myers, A.R.: Erythroid aplasia in systemic lupus erythematosus. Am. J. Med, 55: 706–710, 1973.
3. Bombardier, C., Gladman, D.D., Urowitz, M. B., et al.: The committee on prognosis studies in SLE. Derivation of the SLEDAI. A disease activity index for lupus patients. Arthritis Rheum, 35: 630–640, 1992.
4. Means, R.T. Jr., Dessypris, E.N, Krantz, S. B.: Treatment of refractory pure red cell aplasia with cyclosporine A: disappearance of IgG inhibitor associated with clinical response. Br. J. Haematol, 78: 114–119, 1991.
5. Mamiya, S., Itoh, T., Miura, A.B.: Acquired pure red cell aplasia in Japan. Eur. J. Haematol, 59: 199–205, 1997.
6. Fujii, T., Yajima, T., Kameda, H., Mimori, T., Akizuki, M., Ikeda, Y.: Successful treatment with cyclosporin A of pure red cell aplasia associated with rheumatoid arthritis. J. Rheumatol, 23: 1803–1805, 1996.
7. Wagner, A.D., Goronzy, J.J, Weyand, C.M.: Systemic monocyte and T-cell activation in a patient with human parvovirus B 19 infection. Mayo Clin. Proc, 70: 261–265, 1995.
8. E.F., Fawaz, Human parvovirus infection: Rheumatic manifestations, angioedema, C 1 esterase inhibitor deficiency, ANA positivity, and possible onset of systemic lupus erythematosus, J. Rheumatol, (1996), 23, 1180-1185